A family pharmacy serving every stage of the life journey
First written in FY2023-Q1. 2 of 4 entries say "Restated". Latest entry: FY2026-H1.
Alfresa Holdings moved to the "Worse" side of this theme in 2025.
The whole theme swung hardest in 2025: 1 of 10 companies on the "Worse" side.
0 other companies' latest entry also says "Reframed".
- FY2026-H1ReframedAnnual report
「Apocreat株式会社, a consolidated subsidiary headquartered in Toshima Ward, Tokyo, is pursuing the initiatives identified as key measures in its "25-27 Medium-Term Management Plan" under the theme of "becoming the family pharmacy sought by the community": "enhancing patient-facing services and securing prescriptions," "strengthening the acquisition of prescriptions from sources other than neighboring medical institutions," "expanding new pharmacy functions," and "entering the care services business."」
The wording was revised from "a family pharmacy serving every stage of the life journey" to "a family pharmacy sought by the community," with prescription acquisition, expansion of pharmacy functions and entry into the care services business identified as specific means. - FY2024-Q1RestatedAnnual report
「In the healthcare-related business, we aim to be a “primary care pharmacy” serving every stage of the life journey, from prevention to terminal care, and are promoting the “growth of the business through home healthcare,” “business transformation through DX,” and “initiatives for presymptomatic disease prevention,” identified as priority measures under the “22-24 Medium-Term Management Plan.”」
The Group continues to promote home healthcare, digital transformation and disease prevention before onset, aiming to become a primary-care pharmacy serving every stage of the customer's life journey. - FY2023-Q2RestatedAnnual report
「In the healthcare-related business, we aim to be a “primary care pharmacy” serving every stage of the life journey, from prevention to terminal care, and are promoting the “growth of the business through home healthcare,” “business transformation through DX,” and “initiatives for presymptomatic disease prevention,” identified as priority measures under the “22-24 Medium-Term Management Plan.”」
The company continues to set out a policy of becoming a family pharmacy serving every stage from prevention through terminal care, along with home healthcare, DX and means of preventing disease before its onset. - FY2023-Q1First statedAnnual report
「We aim to be a "family pharmacy" serving every stage of the life journey, from prevention through terminal care」
For the dispensing pharmacy business, the company has set as a new goal becoming a "family pharmacy" serving every stage from prevention through terminal care.